Skip to main content

2017 Bahija Jallal

Bahija Jallal of MedImmune named 2017 Woman of the Year

The Healthcare Businesswomen’s Association (HBA) honored Bahija Jallal, PhD, president of MedImmune and executive vice president of AstraZeneca as its 2017 Woman of the Year. 

“The HBA is extremely proud to honor Bahija Jallal as our 2017 Woman of the Year,” said HBA CEO Laurie Cooke. “Bahija brings her visionary leadership, sharp intellect, and empowering presence to her organization and challenges individuals to think bolder and dream bigger. Bahija’s commitment to mentoring young aspiring women, as well as launching MedImmune’s annual Women’s Summit, exemplifies her dedication to achieving gender parity for healthcare businesswomen.”

Upon receiving the award at the 28th annual Woman of the Year event, Bahija stated, “I am humbled to receive this recognition, and to join the distinguished list of HBA Woman of the Year recipients who have come before me. I am proud to say that at MedImmune, about 50 percent of our employees are female and our leadership team is equally diverse. As the HBA Woman of the Year, it is a privilege for me to represent not only these talented female innovators, but also so many amazing women in the healthcare industry.”

MedImmune is the global biologics research and development arm of AstraZeneca. As executive vice president, AstraZeneca, and president of MedImmune, Bahija is responsible for biologics research, development and clinical activities. Bahija joined MedImmune as vice-president, translational sciences in 2006 and became president of MedImmune in 2013. She has guided MedImmune through an unprecedented expansion of its pipeline; in fact, in 2007 MedImmune accounted for five percent of the overall AstraZeneca pipeline, and today it represents approximately 50 percent. The company now has more than 130 biologics in R&D and 40 products in clinical development. Bahija has authored more than 70 peer-reviewed publications and holds more than 15 patents. She is a member of the American Association for Cancer Research, the American Association of the Advancement of Science, and is president of the board of directors of the Association of Women in Science. Bahija also serves on the board of trustees of the Johns Hopkins University in Baltimore, Maryland.

Pascal Soriot, chief executive officer, AstraZeneca, said, “Every day, Bahija is an inspiration to her staff, the employees of MedImmune and AstraZeneca, countless scientists, business colleagues outside of the company and the hundreds of women and men across the globe who have had an opportunity to work with her in some capacity. She inspires me as well and I am proud of all the work she has done on behalf of patients.”

Read the cover story on Bahija in the April 2017 issue of HBA’s media partner publication, Pharmaceutical Executive magazine.

About the HBA
The Healthcare Businesswomen’s Association (HBA) is a global nonprofit organization serving a community women and men in leading life sciences, biotech, pharmaceutical and supporting companies. The HBA has nearly 120 Corporate Partners and nearly 8,000 members served by more than 20 chapters and affiliates across the U.S. and Europe.